Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.37M | -5.73M | -5.63M | -3.90M | -3.32M |
| Total Depreciation and Amortization | 17.00K | 24.00K | 26.00K | 27.00K | 27.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.00K | 1.25M | 37.00K | -1.11M | -1.94M |
| Change in Net Operating Assets | -646.00K | 1.25M | 1.15M | 348.00K | -2.51M |
| Cash from Operations | -3.93M | -3.21M | -4.42M | -4.63M | -7.74M |
| Capital Expenditure | 0.00 | -8.00K | -14.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -8.00K | -14.00K | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.00K | -32.00K | -7.00K | -19.00K | -17.00K |
| Issuance of Common Stock | 8.07M | 0.00 | 0.00 | 4.98M | 4.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 1.70M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.92M | 5.92M | 0.00 | 1.11M | 4.39M |
| Cash from Financing | 2.13M | 5.89M | 1.69M | 6.07M | 9.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.80M | 2.67M | -2.74M | 1.44M | 1.41M |